Phoenix Holdings Ltd. Brainstorm Cell Therapeutics Inc. Transaction History

Phoenix Holdings Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$3.01 - $4.01 $171,031 - $227,852	-56,821 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$3.46 - $7.88 $404,342 - $920,872	-116,862 Reduced 67.28%	56,821 $214,000
Q4 2020 Feb 11, 2021	BUY	$3.99 - $17.73 $692,995 - $3.08 Million	173,683 New	173,683 $799,000
Q3 2020 Nov 10, 2020	SELL	$11.19 - $16.92 $1.17 Million - $1.77 Million	-104,782 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$4.42 - $12.66 $60,779 - $174,087	-13,751 Reduced 11.6%	104,782 $1.11 Million
Q1 2020 May 20, 2020	BUY	$4.01 - $8.88 $358,718 - $794,369	89,456 Added 307.65%	118,533 $534,000
Q4 2019 Feb 18, 2020	SELL	$3.62 - $4.29 $28,540 - $33,822	-7,884 Reduced 21.33%	29,077 $124,000
Q3 2019 Nov 18, 2019	BUY	$3.54 - $4.48 $130,841 - $165,585	36,961 New	36,961 $138,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.